z-logo
open-access-imgOpen Access
Tirilazad treatment does not decrease early brain injury after transient focal ischemia in cats.
Author(s) -
Reiko Takeshima,
Jeffrey R. Kirsch,
Raymond C. Koehler,
Richard J. Traystman
Publication year - 1994
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.25.3.670
Subject(s) - medicine , cats , anesthesia , ischemia , stroke (engine) , brain ischemia , transient (computer programming) , cardiology , mechanical engineering , computer science , engineering , operating system
We tested the hypothesis that administration of the antioxidant tirilazad mesylate improves electrophysiological recovery and decreases infarct volume after transient focal cerebral ischemia in cats.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom